drugset / Trial / NCT01662440

Safety and Immunogenicity of 2 Different Vaccination Schedules of Rabies and Japanese Encephalitis Vaccines in Healthy Adult Subjects

NCT01662440

Phase 3 Completed 661 enrolled Novartis Vaccines
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Establish non-inferiority of the immune response and evaluate the safety and tolerability of Rabies and Japanese Encephalitis (JE) vaccines given concomitantly or alone and according to either of 2 schedules for preexposure prophylaxis.

Timeline

Start
2012-08
Primary completion
2012-12
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Japanese Encephalitis Vaccine
Subject Rabies Vaccine